3 and supplemental Table 3)
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for diabetes and obesity, exhibit pleiotropic effectsincluding anti-inflammatory, antioxidant, and neuroprotective propertiesthat position them as transformative candidates for ocular therapeutics
other investigations have shown that LFC reduction associated with metabolic disorder improvement and a relative decrease of 30% combined with an improvement in ALT may be predictive of a more active histological response
Studies conducted on humans indicate a dosage of 24 g per day
Working with a dietitian sets you up for success with a custom meal plan and ongoing support as you adjust to the medication and start making the necessary changes to achieve lasting results with the medication
According to Mayo Clinic Diet guidance, following a healthy eating plan with adequate fiber can help avoid or minimize common side effects